2020 Speaker Line-Up

Christina Bender, PhD

Exploratory Biomarker & Oncology Commercialization Lead

Bristol-Myers Squibb

Kimberly Banks

Senior Director, Medical Affairs, BioPharma

Guardant Health

Melissa Gebhardt

Senior Director, GuardantConnect Oncology Trial & Therapy Global Matching Services, Business Development

Guardant Health

An Hendrix

Professor

Ghent University

Darren Hodgson

Global Project Leader & Interim Site Head Translational Medicine Boston

AstraZeneca

Karen Howarth

Head, Cancer Genomics

Inivata

Naveen Kumar

Head, BioPharma Data Business Development

Guardant Health

Pashtoon Kasi

Assistant Professor, College of Medicine & Oncology

University of Iowa

Peter Kuhn, MD, PhD

Professor

University of Southern California

Jean-Francois Martini

Senior Director, Translational Oncology & Lead, Global Product Development

Pfizer

Lauren Leiman

Executive Director

BloodPAC

Yan Li

Director, Oncology Biomarker Strategist

Bayer

Antony Newton

VP Business Development

Inivata

Palani Palaniappan, PhD

Chief Technology Officer

Epic Sciences

Robert McCormack, PhD

Independent

Gary Pestano

Chief Development Officer

Biodesix

Pedram Razavi, MD, PhD

Medical Oncologist

Memorial Sloan Kettering Cancer Center

Sarah Paul

Principal Scientific Researcher & Biomarker Lead

Genentech

Hakan Sakul, PhD

VP & Head, Diagnostics

Pfizer

Howard Scher, MD

Head, Biomarker Development Initiative Member & Attending Physician

Memorial Sloan Kettering Cancer Center

Mark Routbort

MD, Professor, Hematopathology

University of Texas MD Anderson Cancer Center

Leighla Tayefeh

Research Associate, Biomarker Development

Ionis Pharmaceuticals

Daniel Simon

Senior Vice President, BioPharma Business Development

Guardant Health

Robin Toft

Chairman & Founder

Toft Group Executive Search

Jo Vandesompele

Professor & Chief Scientific Officer

Ghent University & Biogazelle